HOME >> BIOLOGY >> NEWS
Flexible electronics could find applications as sensors, artificial muscles

Flexible electronic structures with the potential to bend, expand and manipulate electronic devices are being developed by researchers at the U.S. Department of Energy's Argonne National Laboratory and the University of Illinois at Urbana-Champaign. These flexible structures could find useful applications as sensors and as electronic devices that can be integrated into artificial muscles or biological tissues.

In addition to a biomedical impact, flexible electronics are important for energy technology as flexible and accurate sensors for hydrogen.

These structures were developed from a concept created by Argonne scientist Yugang Sun and a team of researchers at the University of Illinois led by John A. Rogers. The concept focuses on forming single-crystalline semiconductor nanoribbons in stretchable geometrical configurations with emphasis on the materials and surface chemistries used in their fabrication and the mechanics of their response to applied strains.

"Flexible electronics are typically characterized by conducting plastic-based liquids that can be printed onto thin, bendable surfaces," Sun said. "The objective of our work was to generate a concept along with subsequent technology that would allow for electronic wires and circuits to stretch like rubber bands and accordions leading to sensor-embedded covers for aircraft and robots, and even prosthetic skin for humans.

"We are presently developing stretchable electronics and sensors for smart surgical gloves and hemispherical electronic eye imagers," he added.

The team of researchers has been successful in fabricating thin ribbons of silicon and designing them to bend, stretch and compress like an accordion without losing their ability to function. The detailed results of these findings were published in the Journal of Materials Chemistry paper, " Structural forms of single crystal semiconductor nanoribbons for high-performance stretchable electronics," whi
'"/>

Contact: Sylvia Carson
scarson@anl.gov
630-252-5510
DOE/Argonne National Laboratory
2-Apr-2007


Page: 1 2

Related biology news :

1. Flexible genes allow ants to change destiny
2. Deflecting damage: Flexible electronics aid brain injury research
3. Juiced-up battery fueled by sugar could power small portable electronics
4. Solitons could power molecular electronics, artificial muscles
5. New U. of Colorado polymer has applications for dentistry, electronics, automobiles
6. Successful test of single molecule switch opens the door to biomolecular electronics
7. MIT: Recycling of scrapped electronics studied
8. Newly created cancer stem cells could aid breast cancer research
9. New system of wastewater treatment could reduce the size of treatment plants by half
10. Discovery of new protein could provide new understanding of male fertility
11. Einstein researchers prototype vaccine could provide improved protection against tuberculosis

Post Your Comments:
(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
(Date:4/16/2015)... 2015 OncoTAb, Inc., ... Charlotte) spin-out company, announced today the appointment of ... as Chief Operating Officer (COO). Cooper brings to ... developing clinical diagnostic and biotechnology platforms in the ... Cooper’s extensive career transcends the field of medical ...
(Date:4/16/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. ... the orphan disorder, neurotrophic keratopathy (NK), and a ... (DES) in the U.S.  Both trials will be ... Each of these eye disorders was being targeted ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 /PRNewswire/ ... Debiopharm Group ™ , a Swiss-based global biopharmaceutical ... medical needs as well as companion diagnostics, ... investigational compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 ... the 2015 Annual meeting of the American Association for Cancer Research ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
Cached News: